Cargando…
A novel therapeutic strategy of lipidated promiscuous peptide against Mycobacterium tuberculosis by eliciting Th1 and Th17 immunity of host
Regardless of the fact that potent drug-regimen is currently available, tuberculosis continues to kill 1.5 million people annually. Tuberculosis patients are not only inflicted by the trauma of disease but they also suffer from the harmful side-effects, immune suppression and drug resistance instiga...
Autores principales: | Rai, Pradeep K, Chodisetti, Sathi Babu, Nadeem, Sajid, Maurya, Sudeep K, Gowthaman, Uthaman, Zeng, Weiguang, Janmeja, Ashok K, Jackson, David C, Agrewala, Javed N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823727/ https://www.ncbi.nlm.nih.gov/pubmed/27052185 http://dx.doi.org/10.1038/srep23917 |
Ejemplares similares
-
A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis
por: Rai, Pradeep K., et al.
Publicado: (2018) -
A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity
por: Rai, Pradeep K., et al.
Publicado: (2017) -
Potential T cell epitopes of Mycobacterium tuberculosis that can instigate molecular mimicry against host: implications in autoimmune pathogenesis
por: Babu Chodisetti, Sathi, et al.
Publicado: (2012) -
Lipidated promiscuous peptide augments the expression of MHC-II molecules on dendritic cells and activates T cells
por: Gowthaman, Uthaman, et al.
Publicado: (2013) -
Gut Dysbiosis Thwarts the Efficacy of Vaccine Against Mycobacterium tuberculosis
por: Nadeem, Sajid, et al.
Publicado: (2020)